CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-17 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 17,000 | ||
| 2026-04-17 | PATUSKY CHRISTOPHER Director | Option exercise 10b5-1 | +1,000 | $101.80 | $102K | 2,490 |
| 2026-04-17 | PATUSKY CHRISTOPHER Director | Sale 10b5-1 | −1,000 | $578.88 | $579K | 1,490 |
| 2026-04-17 | PATUSKY CHRISTOPHER Director | Option exercise · Stock Option 10b5-1 | −1,000 | 2,910 | ||
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −520 | $573.91 | $298K | 28,356 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,680 | $574.73 | $966K | 26,676 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −789 | $575.64 | $454K | 25,887 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,206 | $576.91 | $1.3M | 23,681 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,085 | $577.87 | $1.2M | 21,596 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,066 | $578.83 | $617K | 20,530 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,454 | $579.64 | $843K | 19,076 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −160 | $581.08 | $93K | 18,916 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −40 | $581.64 | $23K | 18,876 |
| 2026-04-16 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 82,500 | ||
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $573.96 | $230K | 49,613 |
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,800 | $574.79 | $1.0M | 47,813 |
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −930 | $575.99 | $536K | 46,883 |
| 2026-04-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,048 | $577.03 | $1.2M | 44,835 |
Page 122 of 171 · 3,408 trades